Skip to main content

Advertisement

Log in

Correlation of SATB1 overexpression with the progression of human rectal cancer

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background and aims

To date, the association between special AT-rich sequence-binding protein 1 (SATB1) and colorectal cancer (CRC) has not been reported. This study was aimed at investigating the expression and potential role of SATB1 in human rectal cancers.

Methods

Ninety-three paired samples of rectal cancer and distant normal rectal tissue were analyzed by quantitative real-time PCR (qRT-PCR) and immunohistochemistry (IHC), and the correlations between SATB1 expression and clinicopathological parameters were evaluated. The expression profiles of SATB1 were also investigated in a panel of five human colon carcinoma cell lines.

Results

The general level of SATB1 mRNA in rectal cancer tissues was statistically significantly higher than that in normal mucosa (P = 0.043). The rate of positive SATB1 protein expression in rectal cancers (44.1%) was significantly higher than that in normal tissues (25.8%) by IHC analysis (P = 0.009). Overexpression of SATB1 mRNA was more predominant in patients with earlier onset of rectal cancer (P = 0.033). SATB1 expression correlated with invasive depth and tumor node metastasis (TNM) stage at both protein and mRNA levels (P < 0.05). Furthermore, SATB1 expression in the poorly metastatic KM12C cells was significantly lower than the highly metastatic KM12SM and KM12L4A cells and higher than the HCT116 and SW480 cells (P = 0.001). These results were further confirmed by Western blotting.

Conclusion

Our results indicate that SATB1 may play an important role in the progression of human rectal cancer, which represents a possible new mechanism underlying CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130

    Article  PubMed  Google Scholar 

  2. Kouzarides T (1999) Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 9:40–48

    Article  PubMed  CAS  Google Scholar 

  3. Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY, Kohwi-Shigematsu T (2000) The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev 14:521–535

    PubMed  CAS  Google Scholar 

  4. Kumar PP, Purbey PK, Sinha CK, Notani D, Limaye A, Jayani RS, Galande S (2006) Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell 22:231–243

    Article  Google Scholar 

  5. Wen J, Huang S, Rogers H, Dickinson LA, Kohwi-Shigematsu T, Noguchi CT (2005) SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood 105:3330–3339

    Article  PubMed  CAS  Google Scholar 

  6. Cai S, Lee CC, Kohwi-Shigematsu T (2006) SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 38:1278–1288

    Article  PubMed  CAS  Google Scholar 

  7. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452:187–193

    Article  PubMed  CAS  Google Scholar 

  8. Zhao XD, Ji WY, Zhang W, He LX, Yang J, Liang HJ, Wang LL (2010) Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 72:1–5

    Article  PubMed  CAS  Google Scholar 

  9. Lu X, Cheng C, Zhu S, Yang Y, Zheng L, Wang G, Shu X, Wu K, Liu K, Tong Q (2010) SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep 24:981–987

    PubMed  CAS  Google Scholar 

  10. Cheng C, Lu X, Wang G, Zheng L, Shu X, Zhu S, Liu K, Wu K, Tong Q (2010) Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS 118:855–863

    Article  PubMed  CAS  Google Scholar 

  11. Wang S, Zhou J, Wang XY, Hao JM, Chen JZ, Zhang XM, Jin H, Liu L, Zhang YF, Liu J, Ding YQ, Li JM (2009) Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J Pathol 219:114–122

    Article  PubMed  CAS  Google Scholar 

  12. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC Cancer staging manual, 7th edn. Springer, New York, pp 143–164

    Google Scholar 

  13. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45

    Article  PubMed  CAS  Google Scholar 

  14. Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathology 8:138–140

    CAS  Google Scholar 

  15. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) real-time PCR. Nucleic Acids Res 30:e36

    Article  PubMed  Google Scholar 

  16. Zheng J (2008) Is SATB1 a master regulator in breast cancer growth and metastasis? Women’s Health (Lond Engl) 4:329–332

    CAS  Google Scholar 

  17. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T (2002) SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419:641–645

    Article  PubMed  CAS  Google Scholar 

  18. Cai S, Han HJ, Kohwi-Shigematsu T (2003) Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 34:42–51

    Article  PubMed  CAS  Google Scholar 

  19. Yokota J (2000) Tumor progression and metastasis. Carcinogenesis 21:497–503

    Article  PubMed  CAS  Google Scholar 

  20. Purbey PK, Singh S, Notani D, Kumar PP, Limaye AS, Galande S (2009) Acetylation-dependent interaction of SATB1 and CtBP1 mediates transcriptional repression by SATB1. Mol Cell Biol 29:1321–1337

    Article  PubMed  CAS  Google Scholar 

  21. Notani D, Gottimukkala KP, Jayani RS, Limaye AS, Damle MV, Mehta S, Purbey PK, Joseph J, Galande S (2010) Global regulator SATB1 recruits β-catenin and regulates TH2 differentiation in Wnt-dependent manner. PLoS Biol 8:e1000296

    Article  PubMed  Google Scholar 

  22. Kongkanuntn R, Bubb VJ, Sansom OJ, Wyllie AH, Harrison DJ, Clarke AR (1999) Dysregulated expression of β-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice. Oncogene 18:7219–7225

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the National Natural Science Foundation of China (No. 30830100) and Ph.D. Programs Foundation of the Ministry of Education of China (No. 20080610058). We thank Yong Liu and Yang Li for their technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zong-Guang Zhou.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Fig. S1

The relative expressions of SATB1 mRNA in five colon cancer cell lines detected by qRT-PCR. The amplification curves and corresponding Ct values of SATB1 and β-actin gene (reference gene) are shown. The experiment was repeated three times (JPEG 61 kb)

High resolution image (TIFF 539 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meng, WJ., Yan, H., Zhou, B. et al. Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis 27, 143–150 (2012). https://doi.org/10.1007/s00384-011-1302-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-011-1302-9

Keywords

Navigation